Get the Stockscreener App
0.3469
10.80%
0.0338
After Hours:
.35
0.0031
+0.89%
Glycomimetics Inc Stock (GLYC) Forecast
The Glycomimetics Inc (GLYC) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $3.7055, representing a +968.17% increase from the current price of $0.3469. The highest analyst price target is $3.5892, and the lowest is $3.8218.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month GLYC Price Target
Average 5.2796
(+1,422% Upside)
Is Glycomimetics Inc (GLYC) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 53.33 | Neutral |
| STOCH(9,6) | 19.23 | Buy |
| STOCHRSI(14) | 40.43 | Neutral |
| MACD(12,26) | 0.0123 | Sell |
| ADX(14) | 29.10 | Buy |
| William %R | -58.37 | Neutral |
| CCI(14) | -37.97 | Neutral |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.3445
Buy
|
0.339
Buy
|
| MA20 |
0.3726
Sell
|
0.3384
Buy
|
| MA50 |
0.2629
Buy
|
0.2994
Buy
|
| MA100 |
0.2347
Buy
|
0.3811
Sell
|
| MA200 |
0.8895
Sell
|
0.6789
Sell
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, GLYC could be considered a Potential Buy, with 17 technical analysis indicators signaling 8 Buy signals, 5 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on GLYC, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 53.33 indicates that GLYC is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 19.23 indicates that GLYC is oversold. This indicates that GLYC price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 40.43 indicates that GLYC is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 29.1 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -37.97 indicates that GLYC is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term GLYC price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Glycomimetics Inc financial reports and earnings history, Glycomimetics Inc (GLYC) stock could reach $9.1373 by 2030, $9.0243 by 2040 and $26.25 by 2050. See the projected annual prices until 2050 of the Glycomimetics Inc stock below:
- Glycomimetics Inc (GLYC) is expected to reach an average price of $2.9719 in 2035, with a high prediction of $3.5009 and a low estimate of $3.1319. This indicates an $756.69% rise from the last recorded price of $0.3469.
- Glycomimetics Inc (GLYC) stock is projected to chart a bullish course in 2040, with an average price target of $8.6328, representing an $2,389% surge from its current level. The forecast ranges from a conservative $8.7076 to a sky-high $9.0243.
- Our analysts predict Glycomimetics Inc (GLYC) to jump 4,761% by 2045, soaring from $16.96 to an average price of $16.86, potentially reaching $17.13. While $16.96 is the low estimate, the potential upside is significant.
- Glycomimetics Inc (GLYC) stock is expected to climb by 2050, reaching an average of $25.84, a $7,349% jump from its current level. However, a wide range of estimates exists, with high and low targets of $26.25 and $26.04, respectively, highlighting the market's uncertainty.
Glycomimetics Inc Stock (GLYC) Year by Year Forecast
Glycomimetics Inc Stock (GLYC) Price Forecast for 2024
Our forecast for GLYC stock price in 2024 now indicates an average price target of $3.4023 with a high forecast of $6.7309 and a low forecast of $0.0736. The average prediction reflects an increase of +880.76% from the last recorded price of $0.3469.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $3.5829 | $3.8218 | $3.5892 | +932.84% |
Glycomimetics Inc Stock (GLYC) Price Forecast for 2025
Glycomimetics Inc Stock (GLYC) is expected to reach an average price of $5.3842 in 2025, with a high prediction of $6.7375 and a low estimate of $4.0308. This indicates an +1,452% rise from the last recorded price of $0.3469.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $4.2816 | $4.0441 | $3.8816 | +1,134% |
| February, 2025 | $5.0165 | $4.5703 | $4.7165 | +1,346% |
| March, 2025 | $5.7314 | $5.0052 | $5.0414 | +1,552% |
| April, 2025 | $6.725 | $5.7601 | $6.7375 | +1,839% |
| May, 2025 | $6.3199 | $6.3649 | $6.7337 | +1,722% |
| June, 2025 | $5.6448 | $5.9048 | $5.9773 | +1,527% |
| July, 2025 | $5.6034 | $5.7935 | $5.611 | +1,515% |
| August, 2025 | $4.4633 | $4.7983 | $5.1371 | +1,187% |
| September, 2025 | $4.4382 | $4.0308 | $4.0744 | +1,179% |
| October, 2025 | $4.8718 | $4.5598 | $4.4844 | +1,304% |
| November, 2025 | $4.9967 | $4.7993 | $4.7567 | +1,340% |
| December, 2025 | $5.1104 | $4.7629 | $4.8155 | +1,373% |
Glycomimetics Inc Stock (GLYC) Price Forecast for 2026
The predicted value for Glycomimetics Inc (GLYC) in 2026 is set at an average of $4.134. Estimates vary from a peak of $4.7791 to a trough of $3.489, indicating an +1,092% surge from the present price of $0.3469.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $4.1253 | $4.2795 | $4.7791 | +1,089% |
| February, 2026 | $4.0702 | $4.1027 | $3.974 | +1,073% |
| March, 2026 | $3.6801 | $3.9151 | $3.6364 | +960.85% |
| April, 2026 | $3.5337 | $3.489 | $3.5538 | +918.65% |
| May, 2026 | $3.8036 | $4.0036 | $3.9449 | +996.46% |
| June, 2026 | $4.2385 | $4.1398 | $4.1411 | +1,122% |
| July, 2026 | $4.5621 | $4.6447 | $4.4634 | +1,215% |
| August, 2026 | $4.097 | $4.317 | $4.3096 | +1,081% |
| September, 2026 | $4.4507 | $4.4719 | $4.4007 | +1,183% |
| October, 2026 | $4.5056 | $4.6068 | $4.4368 | +1,199% |
| November, 2026 | $4.2205 | $4.4405 | $4.533 | +1,117% |
| December, 2026 | $4.0941 | $4.0941 | $4.0292 | +1,080% |
Glycomimetics Inc Stock (GLYC) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Glycomimetics Inc (GLYC) is $4.1688, with a high forecast of $4.4799 and a low forecast of $3.8578. This indicates an +1,102% increase from the last price of $0.3469.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $4.199 | $4.1728 | $4.169 | +1,110% |
| February, 2027 | $4.1539 | $4.1322 | $4.1677 | +1,097% |
| March, 2027 | $4.2675 | $4.2826 | $4.2375 | +1,130% |
| April, 2027 | $4.5124 | $4.3112 | $4.3324 | +1,201% |
| May, 2027 | $4.5473 | $4.5486 | $4.4799 | +1,211% |
| June, 2027 | $4.4009 | $4.3122 | $4.446 | +1,169% |
| July, 2027 | $4.2058 | $4.2171 | $4.2697 | +1,112% |
| August, 2027 | $4.3109 | $4.1846 | $4.2025 | +1,143% |
| September, 2027 | $4.4328 | $4.4895 | $4.4507 | +1,178% |
| October, 2027 | $4.3219 | $4.3506 | $4.3531 | +1,146% |
| November, 2027 | $4.162 | $4.2827 | $4.2552 | +1,100% |
| December, 2027 | $3.7781 | $3.8578 | $4.1129 | +989.11% |
Glycomimetics Inc Stock (GLYC) Price Forecast for 2028
In 2028, Glycomimetics Inc (GLYC) is projected to reach an average price of $2.2742, with a high projection of $3.7589 and a low estimate of $0.7896. This indicates an +555.59% rise from the last price of $0.3469.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.7973 | $3.7852 | $3.7427 | +994.64% |
| February, 2028 | $3.8559 | $3.8088 | $3.7589 | +1,012% |
| March, 2028 | $3.5729 | $3.5912 | $3.6963 | +929.96% |
| April, 2028 | $2.0761 | $2.3161 | $3.475 | +498.48% |
| May, 2028 | $1.6998 | $1.8598 | $1.8949 | +389.99% |
| June, 2028 | $1.2847 | $1.1559 | $0.7748 | +270.33% |
| July, 2028 | $0.2396 | $0.7896 | $0.6308 | -30.94% |
| August, 2028 | $2.2532 | $1.987 | $1.9532 | +549.52% |
| September, 2028 | $2.1681 | $2.1506 | $2.1481 | +524.99% |
| October, 2028 | $1.783 | $1.9565 | $1.8943 | +413.98% |
| November, 2028 | $1.2566 | $1.3066 | $1.2479 | +262.24% |
| December, 2028 | $1.2915 | $1.3128 | $1.1229 | +272.30% |
Glycomimetics Inc Stock (GLYC) Price Forecast for 2029
The 2029 price forecast for Glycomimetics Inc Stock (GLYC) is $4.0211 on average, with a high prediction of $8.00 and a low estimate of $0.0422. This represents an +1,059% increase from the previous price of $0.3469.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.2351 | $1.2651 | $1.2602 | +256.05% |
| February, 2029 | $1.10 | $1.19 | $1.1839 | +217.11% |
| March, 2029 | $1.215 | $1.1275 | $1.12 | +250.23% |
| April, 2029 | $1.0799 | $1.1711 | $1.1137 | +211.29% |
| May, 2029 | $1.1435 | $1.1448 | $1.1673 | +229.63% |
| June, 2029 | $0.4984 | $0.6184 | $0.8422 | +43.67% |
| July, 2029 | $0.2667 | $0.2046 | $0.6667 | -23.11% |
| August, 2029 | $1.0631 | $0.138 | $1.5631 | +206.46% |
| September, 2029 | $1.0882 | $0.8144 | $1.5482 | +213.69% |
| October, 2029 | $1.2746 | $0.8133 | $1.4846 | +267.42% |
| November, 2029 | $0.3947 | $0.3497 | $1.5671 | +13.77% |
| December, 2029 | $8.98 | $0.0422 | $8.00 | +2,489% |
Glycomimetics Inc Stock (GLYC) Price Forecast for 2030
Glycomimetics Inc Stock (GLYC) is expected to reach an average price of $12.87 in 2030, with a high forecast of $16.86 and a low forecast of $8.8871. This signifies an +3,611% surge from the last price of $0.3469.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $9.6273 | $9.4248 | $9.1373 | +2,675% |
| February, 2030 | $7.8471 | $8.8871 | $8.9247 | +2,162% |
| March, 2030 | $11.26 | $9.4445 | $11.13 | +3,145% |
| April, 2030 | $16.82 | $16.93 | $16.86 | +4,749% |
| May, 2030 | $15.49 | $15.52 | $16.32 | +4,366% |
| June, 2030 | $14.44 | $14.87 | $15.30 | +4,064% |
| July, 2030 | $14.30 | $13.48 | $13.85 | +4,023% |
| August, 2030 | $13.50 | $13.48 | $13.19 | +3,792% |
| September, 2030 | $13.90 | $13.52 | $13.29 | +3,907% |
| October, 2030 | $14.21 | $14.06 | $14.00 | +3,997% |
| November, 2030 | $15.68 | $14.39 | $14.77 | +4,421% |
| December, 2030 | $15.85 | $15.83 | $15.81 | +4,468% |
1.61%
1.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):